Articles On Genetic Technologies (ASX:GTG)

Local stocks tracked higher on Friday in a relatively calm session to end the week. The ASX200 traded flat, edging higher by 0.36% into the close. Those gains were comfortably outpaced by the small end of town, as the microcap Emerging Comp...

The ASX had another positive day but, unlike yesterday, held momentum to close at an all time high. The ASX 200 closed at 7,511 points which was an 0.11% gain although the ASX Emerging Companies Index fell 0.63% to 2,226 points. The top sec...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

The ASX rebounded from yesterday’s losses but short of an all time high. The ASX 200 closed at 7,503 points, 0.38% up from yesterday but 6 points behind its intraday high. Meanwhile the ASX Emerging Companies Index gained 0.63% at 2,240 poi...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

The ASX finished Hump Day nearly a third of one per cent higher. The ASX 200 closed at 7,355 which is 0.31 per cent higher than yesterday while the ASX Emerging Companies Index closed 0.14 per cent higher at 2,193. It was a mostly positive...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.   WINNERS Scr...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.   WINNERS Scr...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Point of care diagnostic test provider Lumos Diagnostics (ASX:LDX) is set to list on the ASX on July 5. The company was founded in Melbourne in 2015 and is still headquartered there but has manufacturing facilities in California and Florida...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Small caps have dipped for a second straight day following their seven-day winning streak. The Small Ordinaries index closed yesterday down 12.1 points, or 0.37 per cent, to 3,278.8. Larger companies fared a little bit better, with the ASX2...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

It was a good day for some of ASX-listed cancer therapy stocks yesterday, with three companies releasing seperate announcements that sent their share prices higher. Cancer therapy stocks Invion (ASX:IVX), Immutep (ASX:IMM), and Imugene (ASX...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Molecular diagnostics company Genetic Technologies (ASX:GTG)  has announced the appointment of Michael Tonroe as its new chief financial officer.

Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Summary ikeGPS (ASX:IKE) entered into a deal with Visual Globe’s AI platform to acquire its certain assets for the global communications and the electric utility market. The deal includes an initial payment of US$3.3 million in cash an...

04 Jan 2021 - Genetic Technologies (ASX:GTG) has appointed Simon Morriss to the role of Chief Executive Officer.

While genetic testing has gained immense popularity for its ability to diagnose monogenic mutations, experts believe that Polygenic Risk Score (PRS) is the future of predictive testing. Unlike genetic testing that captures only inherited di...

A quick wrap of the ASX’s key winners and losers on Tuesday, August 25. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 782 stocks rose, 682 declined and...

By Tim Boreham, Editor, The New Criterion The ASX biotechs surfing the COVID-19 story Normally investors shun speculative plays in times of market uncertainties, but that’s not been the case with ASX-listed life sciences stocks across the d...

Normally investors shun speculative plays in times of market uncertainties, but that’s not been the case with ASX-listed life science stocks across the drug, diagnostics and device sectors. Naturally, the biotechs drawing a connection with...

Summary The periodic return on a stock is the major determinator for an investor to make an investment in it, be it in the form of dividends or capital appreciation. In the last 3 months period, GTG has given a positive return of 100% t...

Mesoblast and Genetic Technologies renew investor interest with products fighting the virus.

A quick wrap of the ASX’s key winners and losers on Tuesday, July 21. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 1032 ASX stocks rose, 38...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

A quick wrap of the ASX’s key winners and losers on Thursday, July 16. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 604 stocks rose, 684 de...

One of the inconveniences of COVID-19 tests is that they can take several hours to complete. A number of ASX stocks are attempting to create faster tests, including two that surged this morning. AnteoTech Ltd (ASX:ADO), which said it has es...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

A quick wrap of the key winners and losers on Tuesday, June 16. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. The benchmark ASX200 Index bounced b...

In the past fortnight there were over 30 directors trades of $100,000 or more among ASX small cap directors. The list included multiple groups of directors. Five directors from water treatment stock Phoslock (ASX:PET) put in $1.3m between t...

A quick wrap of the key winners and losers on Tuesday, June 2. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day.   Code Name Price % Chg...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Melbourne-based company Genetic Technologies (ASX:GTG) has updated on the development of its genetic test for the COVID-19 virus.

A vaccine for COVID-19 is expected to take a long time to develop and the company is confident its genetic test will be another bullet in the armoury to fight the virus in the meantime.

Dual-listed Genetic Technologies (ASX:GTG | NASDAQ: GENE) is fast-tracking development of a genetic test that will determine if people are at a high risk of contracting COVID-19. The company is to commence accelerating development of a poly...

Luck’s a fortune, eh? Atomo Diagnostics’ (ASX:AT1) ASX listing had been in the offing for months, based on its rapid blood-based diagnostic device for HIV that’s the only self-administered HIV assay approved by the local Therapeutic Goods A...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Molecular diagnostics company Genetic Technologies (ASX: GTG) has thrown its weight towards mitigating the effects of COVID-19 by drafting a “detailed implementation plan” that could see its genetic testing facilities transformed into a hig...

Today three more ASX small caps entered the fight against COVID-19 and all of them are notching share price gains. The candidates PharmAust (ASX:PAA), Harris Technology (ASX:HT8) and Genetic Technologies (ASX:GTG) all rose by at least 30 pe...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...